Skip to content
10-K

Annual Report

9 Meters Biopharma, Inc.

0001551986-23-000021

← back to feed
Filed
Mar 28, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 24, 2023 14.34M sh
Shares Diluted FY 2022 · Dec 31, 2022 12.96M sh
Shares Diluted restated FY 2022 · Dec 31, 2021 12.16M sh
Capex FY 2022 · Dec 31, 2022 $2.84K
Capex FY 2022 · Dec 31, 2021 $12.48K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$37.24M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$29.48M
Cash And Equivalents FY 2022 · Dec 31, 2022 $12.65M
Cash And Equivalents FY 2022 · Dec 31, 2021 $46.99M
Stockholders Equity FY 2022 · Dec 31, 2022 $2.4M
Stockholders Equity FY 2022 · Dec 31, 2021 $41.6M
Stockholders Equity FY 2022 · Dec 31, 2020 $32.14M
Current Liabilities FY 2022 · Dec 31, 2022 $30.7M
Current Liabilities FY 2022 · Dec 31, 2021 $8.46M
Total Liabilities FY 2022 · Dec 31, 2022 $30.75M
Total Liabilities FY 2022 · Dec 31, 2021 $8.57M
Current Assets FY 2022 · Dec 31, 2022 $33.02M
Current Assets FY 2022 · Dec 31, 2021 $49.99M
Total Assets FY 2022 · Dec 31, 2022 $33.15M
Total Assets FY 2022 · Dec 31, 2021 $50.17M
Eps Diluted FY 2022 · Dec 31, 2022 −$3.38
Eps Diluted restated FY 2022 · Dec 31, 2021 −$3.03
Eps Basic FY 2022 · Dec 31, 2022 −$3.38
Eps Basic restated FY 2022 · Dec 31, 2021 −$3.03
Sga Expense FY 2022 · Dec 31, 2022 $11.01M
Sga Expense FY 2022 · Dec 31, 2021 $9.66M
Net Income FY 2022 · Dec 31, 2022 −$43.77M
Net Income FY 2022 · Dec 31, 2021 −$36.78M
Operating Income FY 2022 · Dec 31, 2022 −$42.02M
Operating Income FY 2022 · Dec 31, 2021 −$36.76M